Scaling Synthetic Biology (with Ginkgo’s Reshma Shetty)

Azeem Azhar's Exponential View

EPIIPLUS 1 Ltd / Azeem Azhar

Openai, Intelligence, It, Society, Technology, Review, Ai, Investing, Science, Economy, Business, Artificial Intelligence, Automation, Robots, Exponential, Future, Tech News, Work, Government, Exponential View, Economics, News, Gpt, Azeem Azhar

5 • 1.1K Ratings

🗓️ 23 February 2022

⏱️ 50 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Science is getting better at re-engineering micro-organisms for all kinds of uses, from better medical treatments to more durable materials. But there are still hurdles to overcome, including scaling. Boston-based Ginkgo Bioworks was one of the first billion-dollar companies in the synthetic biology space. The NYSE-listed company uses machine learning and automation to coax biology to work at industrial scale. COO Reshma Shetty talks to Azeem Azhar about the company’s technology, business model, and how big she thinks synthetic biology could become.

Transcript

Click on a timestamp to play from that location

0:00.0	There's no shortage of tech podcasts, but few give you a true dose of the future.
0:06.0	The A16Z podcast is an exception.
0:09.0	It takes you straight to the innovators behind new materials, data centers, self-driving cars,
0:14.0	even electric boats, eavesdrop on the future with the A16Z podcast.
0:24.0	HBR presents.
0:35.0	Welcome to Exponential View with me, Azim Azar.
0:38.0	The world is changing at an amazing pace.
0:41.0	We're entering the exponential age, propelled by radical, remarkable technologies.
0:46.0	And on this podcast, I want to explore the themes, topics and questions that will help you make sense of it.
0:52.0	I want to turn chaos into clarity and help you make better decisions, to make the right choices over the coming years,
0:59.0	whether that's in business, in policy or in your career.
1:02.0	The exponential age has one certainty and that is uncertainty.
1:07.0	But over the next 45 minutes or so, my guest and I will try to shine just a little light on that darkness.
1:13.0	And if we do that, please take a moment to share this podcast with a few friends.
1:18.0	Part of what we're trying to do at Exponential View is make space for open discussion about how our world is changing.
1:24.0	And that starts with you.
1:26.0	This week, I'm talking to Reshma Shetty, the co-founder and chief operating officer of Ginkgo Bioworks.
1:32.0	Ginkgo is using automation and machine learning to accelerate the process of designing microorganisms,
1:37.0	which could create valuable molecules that we can use in medicine, food, industry and indeed any number of other sectors.
1:45.0	The potential market for synthetic biology is huge.
1:48.0	And Ginkgo is one of the leaders in the race to address it.
1:51.0	Reshma Shetty, welcome to Exponential View.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from EPIIPLUS 1 Ltd / Azeem Azhar, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of EPIIPLUS 1 Ltd / Azeem Azhar and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.